Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized 3% Hypertonic Saline vs Normal Saline in Acute Bronchiolitis
NCT07138625Not yet recruiting
- Sponsor
- University of Anbar
- Start
- Oct 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules, Device-based Delivery
01
Overview
Randomised, double-blind trial of hypertonic saline in acute bronchiolitis (2 arms), sponsored by University of Anbar. Primary endpoint: Length of Hospital Stay. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
hypertonic saline
03
Conditions
acute bronchiolitis
Beyond the preview
Go deeper on NCT07138625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07138625.